Benzinga | Jul 13, 2021 04:06PM EDT

Nurix Therapeutics Q2 EPS $(0.60), Sales $7.09M Up From $4.18M YoY

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.60) per share. The company reported $7.09 million in sales this quarter. This is a 69.56 percent increase over sales of $4.18 million the same period last year.